This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bioright Worldwide Company Limited. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: Innovations of Yuk Sun Lui
Introduction
Yuk Sun Lui is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of biotechnology, particularly in the development of enzyme mutants that enhance industrial applications. With a total of 2 patents, his work focuses on improving the stability and activity of important enzymes.
Latest Patents
Yuk Sun Lui's latest patents include innovations in penicillin expandase mutants and deacetoxycephalosporin C hydroxylase mutants. The first patent details penicillin expandase mutants that utilize SEQ ID NO.: 2 as a reference sequence. These mutants exhibit at least one amino acid mutation at specific residue positions, resulting in increased thermostability and catalytic activity, making them more suitable for commercial and industrial applications. The second patent focuses on deacetoxycephalosporin C hydroxylase mutants, characterized by mutations that lead to at least a 10% increase in activity and a 150% increase in thermostability compared to the wild-type enzyme. This advancement allows for greater commercial viability.
Career Highlights
Yuk Sun Lui is currently associated with Bioright Worldwide Company Limited, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in various industries, particularly in pharmaceuticals.
Collaborations
Yuk Sun Lui collaborates with talented individuals such as Shiu Ming Cheng and Yau Lung Siu, who contribute to his research and development efforts.
Conclusion
Yuk Sun Lui's contributions to biotechnology through his innovative patents demonstrate his commitment to enhancing industrial applications of enzyme technology. His work not only advances scientific knowledge but also holds promise for practical applications in various sectors.